This conference hosted by the Department of Biotechnology, Indian Institute of Technology Madras (IITM) will bring together scientists from IITs, Indian Institute of Science and Educational Research (IISERs) and Indian Institute of Science (IISc) as well as International research community to discuss innovation in cancer genomics, drug development, target selection and the impact of new discoveries in personalized treatment strategies. Despite the untiring efforts in the combat of cancer, understanding tumor heterogeneity has been the greatest challenge in developing a universal treatment strategy.

Researchers have come up with precision medicine and personalized treatment strategies to circumvent these challenges with the help of advancements in cancer genomics. This conference would provide a platform for eminent and emerging cancer researchers from India (IITs, IISERs and IISc) and other countries to meet, discuss and establish collaboration to achieve the above goal. The meeting will cover presentations from cancer genomics with special focus on the advancement in the precision medicine front as well as the development of personalized treatment modalities covering the broad areas: cancer functional genomics, cancer immunogenomics, epigenomics, metabolomics, cancer mouse models and the translation and clinical impact of scientific results.

Chennai is the capital of the South Indian State of Tamil Nadu. It is the fourth largest metropolis of India. Chennai is a seaside (and a major port) city where the sea is a rhapsodist blue, hugging the second largest beach in the world. It has many monuments and temples exemplifying the contributions of the Chola and Pallava Dynasties to the ancient Dravidian civilization. Chennai also has ancient churches and Cathedrals pointing to British heritage of 150 years. The weather is pleasant in January with temperature hovering in the range of 25-30 degree Celsius and humidity in the order 40-60%.

IIT-Madras, Chennai is one of the premier institutes of research and teaching in India. Established in 1958 has been in the frontline of training graduates who fill a significant space all over the world in the field of technology. The biotechnology division of this reputed institute is 16 years old and has already contributed many milestones in this field. The ever so growing specialties in this department is matched none less by the cancer biology division.

The Bhupat and Jyoti Mehta Family Foundation had a modest beginning in 1998 with the objective of empowering people through its philanthropic activities. It provides educational loans to students, funds university scholarships, medical research, and child welfare projects. The Foundation has been the principal sponsor of both Block I & II of the Bhupat & Jyoti Mehta School of Biosciences, at the Indian Institute of Technology Madras, Chennai.

We are looking forward to an inclusive conference that would provide an opportunity for stimulating interaction with the participants.